科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/18 | 4,052 | 4,100 | 4,042 | 4,091 | +71 | +1.8% | 80,900 |
| 2025/04/17 | 4,009 | 4,020 | 3,959 | 4,020 | +10 | +0.2% | 87,900 |
| 2025/04/16 | 4,035 | 4,065 | 3,985 | 4,010 | -16 | -0.4% | 158,800 |
| 2025/04/15 | 4,008 | 4,077 | 3,991 | 4,026 | +48 | +1.2% | 132,400 |
| 2025/04/14 | 4,086 | 4,097 | 3,971 | 3,978 | -38 | -0.9% | 262,800 |
| 2025/04/11 | 4,165 | 4,165 | 3,995 | 4,016 | -359 | -8.2% | 381,100 |
| 2025/04/10 | 4,405 | 4,410 | 4,290 | 4,375 | +180 | +4.3% | 262,800 |
| 2025/04/09 | 4,465 | 4,485 | 4,095 | 4,195 | -270 | -6% | 450,500 |
| 2025/04/08 | 4,400 | 4,465 | 4,313 | 4,465 | +129 | +3% | 332,900 |
| 2025/04/07 | 4,244 | 4,405 | 4,164 | 4,336 | -105 | -2.4% | 399,200 |
| 2025/04/04 | 4,433 | 4,459 | 4,369 | 4,441 | +8 | +0.2% | 174,500 |
| 2025/04/03 | 4,451 | 4,479 | 4,376 | 4,433 | -62 | -1.4% | 259,400 |
| 2025/04/02 | 4,498 | 4,515 | 4,442 | 4,495 | +6 | +0.1% | 172,900 |
| 2025/04/01 | 4,510 | 4,527 | 4,487 | 4,489 | +8 | +0.2% | 149,500 |
| 2025/03/31 | 4,518 | 4,526 | 4,427 | 4,481 | -62 | -1.4% | 185,300 |
| 2025/03/28 | 4,519 | 4,553 | 4,470 | 4,543 | -45 | -1% | 118,200 |
| 2025/03/27 | 4,540 | 4,588 | 4,511 | 4,588 | +2 | ±0% | 167,600 |
| 2025/03/26 | 4,600 | 4,600 | 4,523 | 4,586 | +7 | +0.2% | 198,900 |
| 2025/03/25 | 4,585 | 4,606 | 4,531 | 4,579 | +4 | +0.1% | 132,000 |
| 2025/03/24 | 4,716 | 4,717 | 4,547 | 4,575 | -141 | -3% | 399,800 |
| 2025/03/21 | 4,715 | 4,782 | 4,698 | 4,716 | +1 | ±0% | 351,100 |
| 2025/03/19 | 4,704 | 4,821 | 4,695 | 4,715 | +24 | +0.5% | 288,500 |
| 2025/03/18 | 4,735 | 4,824 | 4,685 | 4,691 | -39 | -0.8% | 311,400 |
| 2025/03/17 | 4,776 | 4,776 | 4,715 | 4,730 | -46 | -1% | 235,000 |
| 2025/03/14 | 4,724 | 4,776 | 4,704 | 4,776 | -10 | -0.2% | 344,300 |
| 2025/03/13 | 4,790 | 4,795 | 4,738 | 4,786 | -37 | -0.8% | 203,900 |
| 2025/03/12 | 4,712 | 4,901 | 4,712 | 4,823 | +74 | +1.6% | 415,900 |
| 2025/03/11 | 4,757 | 4,800 | 4,710 | 4,749 | -8 | -0.2% | 376,100 |
| 2025/03/10 | 4,793 | 4,801 | 4,727 | 4,757 | -24 | -0.5% | 204,600 |
| 2025/03/07 | 4,722 | 4,781 | 4,675 | 4,781 | +28 | +0.6% | 277,300 |
| 2025/03/06 | 4,804 | 4,818 | 4,743 | 4,753 | -51 | -1.1% | 367,300 |
| 2025/03/05 | 4,671 | 4,809 | 4,654 | 4,804 | +151 | +3.2% | 437,600 |
| 2025/03/04 | 4,634 | 4,705 | 4,625 | 4,653 | +38 | +0.8% | 268,900 |
| 2025/03/03 | 4,556 | 4,615 | 4,555 | 4,615 | +63 | +1.4% | 282,400 |
| 2025/02/28 | 4,585 | 4,659 | 4,480 | 4,552 | -27 | -0.6% | 383,900 |
| 2025/02/27 | 4,524 | 4,609 | 4,510 | 4,579 | +147 | +3.3% | 569,500 |
| 2025/02/26 | 4,434 | 4,507 | 4,394 | 4,432 | +49 | +1.1% | 110,500 |
| 2025/02/25 | 4,382 | 4,394 | 4,355 | 4,383 | +4 | +0.1% | 91,500 |
| 2025/02/21 | 4,409 | 4,434 | 4,323 | 4,379 | -21 | -0.5% | 120,400 |
| 2025/02/20 | 4,439 | 4,443 | 4,380 | 4,400 | -92 | -2% | 147,800 |
| 2025/02/19 | 4,460 | 4,530 | 4,420 | 4,492 | +33 | +0.7% | 351,400 |
| 2025/02/18 | 4,529 | 4,585 | 4,459 | 4,459 | +99 | +2.3% | 175,600 |
| 2025/02/17 | 4,360 | 4,423 | 4,360 | 4,360 | +13 | +0.3% | 96,100 |
| 2025/02/14 | 4,302 | 4,347 | 4,297 | 4,347 | +47 | +1.1% | 60,400 |
| 2025/02/13 | 4,269 | 4,322 | 4,269 | 4,300 | +35 | +0.8% | 81,600 |
| 2025/02/12 | 4,279 | 4,297 | 4,234 | 4,265 | +15 | +0.4% | 111,300 |
| 2025/02/10 | 4,239 | 4,275 | 4,198 | 4,250 | -1 | ±0% | 115,200 |
| 2025/02/07 | 4,203 | 4,388 | 4,195 | 4,251 | -92 | -2.1% | 205,000 |
| 2025/02/06 | 4,330 | 4,355 | 4,294 | 4,343 | +65 | +1.5% | 205,400 |
| 2025/02/05 | 4,200 | 4,278 | 4,195 | 4,278 | +73 | +1.7% | 118,200 |
1～
50
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 409,100円 | +30.5% | +111.0% | 4.64% | 11.53倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 362,200円 | +7.9% | +8.9% | 3.42% | 7.75倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 187,000円 | +5.0% | +1.5% | 0.00% | 16.05倍 | 4.27倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 371,000円 | +14.5% | -2.3% | 2.43% | 13.57倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 239,900円 | - | - | 0.00% | - | 111.12倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
